AlzIndiana

Alzheimer's Association Greater Indiana Chapter | alz.org/indiana

[alzindiana]

Love Letters to #EndALZ: Syd

For our fourth and final Love Letter Spotlight, we're honored to share a powerful message from Syd Parker, Director of Field Marketing and Communications at the Greater Indiana Chapter and a granddaughter forever shaped by love.

In her letter, Syd writes directly to Alzheimer’s, honoring her grandma whose imagination, creativity, and joy still ripple through her family today. Though the disease took memories, it did not take her impact.

Read Syd's full love letter below.

Dear Alzheimer’s,

You messed with the wrong grandma.

Growing up, I used to tell other kids that my grandma wasn’t like theirs. While they groaned about spending the day at grandma’s house, I was counting down the minutes. Time with her meant downtown Chicago adventures, 90’s movie marathons, afternoons on the beach, conversations about our wildest dreams, and spontaneous encounters with artists who lived in her building and taught me how to see the world differently. She didn’t just entertain me. She expanded me.

My grandma wasn’t like other grandmas. She had the most magical soul. The kind of woman who made strangers feel like old friends and ordinary moments feel electric. She was witty, fearless, endlessly curious, and deeply kind. She didn’t just love life. She devoured it. And somehow, she made everyone around her feel bigger just by being near her.

She wasn’t only my grandma. She was my friend. My creative muse. An actress, a dreamer, a hippie through and through. She believed in imagination, in possibility, in living loudly and loving fully. She taught me that life wasn’t meant to be played small.

Then Alzheimer’s came.

You took memories. You stole words. You chipped away at moments we thought we’d always have. You tried to rewrite her story.

But here’s what you didn’t take: her impact.

Her charm still lives on in every person she touched. In the laughter she sparked. In the confidence she planted. In the creativity she awakened. In the love she poured into her children, her grandchildren, her friends, and even strangers who crossed her path. You may have taken time from us, but you couldn’t take her from us.

She passed in February 2022, but she is everywhere. In the way I see beauty. In how I chase dreams. In the stories I tell. In the courage I carry forward. She lives on in every brave, joyful, imaginative step her people take.

So no, Alzheimer’s… you didn’t win. You messed with the wrong grandma.

And her love is still stronger than you.

With love,

Syd

[alzindiana]

Love Letters to #ENDALZ: Marty

We’re honored to share a love letter from Marty Posch, former caregiver to his mother and current board member, as he reflects on the journey they walked together through Alzheimer’s.

In his letter, Marty shares a simple yet powerful message: thank you. His words are a moving reminder of the quiet strength of caregivers and the deep honor that can live alongside grief.

Read his full letter below.

Thank you.

Mom. You have been gone for 2.5 years. During that time I have done a lot of healing. As I continued to search through feelings of the last 10 years you were with me battling ALZ I realized that there was something that I never told you. Thank you.

Thank you for trusting me to take care of you. Thank you for always hugging me like I was leaving for college even though you had seen me yesterday. Thank you for always trusting me with a smile when you were scared and confused. Thank you for knowing that while every decision that I made wasn’t right, it was always made with love. Thank you for giving me more time with you in the last 10 years than I had the previous 25. And thank you for letting me be with you when you took your last breath.

As a caregiver I was so wrapped up in the day to day responsibilities and sometimes stress and anxiety that come with caring for someone with ALZ, that I never stopped, took a deep breath and said thank you. It was a responsibility that I was truly honored to have with you.

I miss you so much.

Marty

[alzindiana]

Love Letters to #ENDALZ - Jordan

Meet Jordan Hanscom, a member of the Do What You Love to End ALZ executive leadership team, who shares a heartfelt love letter honoring her Grammy,  the woman who shaped her values, her family, and her commitment to ending Alzheimer’s.

Read Jordan's full letter below.

Dear Grammy,

I think about you often, especially when I look at the family I’ve built and the life that continues to take shape. So much of who I am and who I aspire to be comes from you. Your kindness, your compassion, the way you loved deeply and showed up for others have become the blueprint I follow every day. The values you lived by didn’t disappear when you left; they instead took root in me and continue to grow through my children, my choices and the home I’ve created. I hope you can see how present you still are in all of it.

I hope you would be proud of the legacy you left behind. Not just in memories, but in the way your love continues to ripple outward, shaping our entire family’s future generations. You taught us how to love deeply, serve others, and be a constant in everyone’s lives.  Those lessons have stayed with me more than you could ever know. I have spent a lot of time these past few months thinking of you as we will welcome our third son due to arrive on your birthday. I wish you would be able to hold him in your arms. You were always the happiest with your grandchildren.

Your battle with Alzheimer’s changed me in ways I’m still discovering. Watching you face that disease with such grace is what led me to become involved with the Alzheimer’s Association. I do it for you—for the woman you were, for the parts of you that never faded, and for other families walking that same painful path. Carrying your story forward feels like another way to keep you close. I miss you always, and I hope you know how deeply you are loved. 

All my love,

Jordan

[alzindiana]

Love Letters to #ENDALZ - Claire Becher

💌 #WrittenWithLoveWednesday

Meet Claire Becher, a sophomore at North Central High School, whose love letter honors her Papa - the man who inspired her passion for fundraising and finding a cure for Alzheimer’s. 

From selling bracelets in elementary school, to now leading her own team, Claire's journey is rooted in love and commitment to ensuring no family walks this road alone. 

Read Claire's full letter below.

Dear Papa,

There are so many things I wish I could say to you. But most of all, I want to say thank you. Thank you for teaching me how to fundraise, and thanks for instilling the value of finding a cure for Alzheimer's in me.

I have absolutely no clue how you found the strength to support your wife while her sister forgot everything, and then one day forgot how to breathe. I cannot fathom the pain you were in as your mother, who single-handedly raised you, forgot who you are.

Without you, I never would have been able to find the Alzheimer's Association. I remember when I first mentioned that I wanted to raise money for Alzheimer's. I was a fourth grader who just wanted to find a way to help other people, so nobody else had to go through the pain of knowing that their beloved great aunt no longer knew who they are. I mentioned wanting to sell bracelets, and you told me about a website that I can send the money to, and they would use the money to provide support for caregivers and research. You let me join your team, and provided me with new ideas, help, and inspiration.

Now that you're gone, I had to start my own team. That was one of the hardest things I've ever done, because I finally had to accept that we wouldn't be able to work together fundraising anymore. I felt the pressure of trying to make up the true dedication that you poured into fundraising with The Village Parrotheads. I'm still in disbelief that you and the Parrotheads were able to raise over $50,000 a year.

I'm incredibly lucky, because my other grandpa helped me to set up a meeting with the staff of the Greater Alzheimer's Association of Indiana, and they provided me with opportunities to be more involved in the Association and allowed me to share our story. I only wish more people knew about the incredible support they provide at alz.org/help-support.

I'm also fortunate because of our incredibly supportive family. Both your siblings and your in-laws have supported me in this fundraising, both with money and words of motivation. My other side of the family has been extremely supportive as well, especially my other grandpa. His commitment to helping retired people understand Alzheimer's leaves me in awe, much like your commitment to fundraising did.

There's so many things I love about you, but I'm most grateful for the passion for fundraising for the Alzheimer's Association that you ingrained in me.

Love you always, Claire

[alzindiana]

ALZHEIMER’S ASSOCIATION AWARDS FOUR 2025 PERELMAN FELLOWSHIP GRANTS

From left to right: Sunwoo Chung, Ph.D., Claudia Mera Reina, M.D., Ph.D., Claudia Rangel-Barajas, Ph.D. (not pictured: Miguel Moutinho, PharmD, Ph.D.

The Alzheimer’s Association today announced the recipients of the 2025 Dr. Mel Perelman Fellowship for Alzheimer’s Research, awarding four early-career investigators at the Indiana University School of Medicine whose work shows exceptional promise for advancing the understanding, treatment, and prevention of Alzheimer’s disease and related dementias.

Established in 2023 through a partnership between the Alzheimer’s Association and the IU School of Medicine, the Perelman Fellowship honors the legacy of Dr. Mel Perelman, a respected scientist, mentor, and community leader who was deeply committed to nurturing the next generation of researchers.

This prestigious fellowship is open exclusively to IU School of Medicine researchers and is designed to support innovative projects with strong potential for near-term clinical significance. Funding spans the full research continuum, from basic discovery science to social, behavioral, and translational studies addressing Alzheimer’s disease and related dementias.

Now in its third consecutive year, the program selected four fellows from a highly competitive applicant pool. Each recipient will receive $205,000 to support their individual research projects, along with travel support to attend the 2026 Alzheimer’s Association International Conference (AAIC) in London, the world’s largest gathering of dementia researchers and clinicians.

Applicants are vetted and selected by the Alzheimer’s Association Medical and Scientific Advisory Group and the Perelman Fellowship selection committee. Thank you to the leadership and guidance of Heather Snyder, Ph.D., senior vice president of medical and scientific relations at the Alzheimer’s Association; Natalie Sutton, MPA, executive director of the Alzheimer’s Association Greater Indiana Chapter; and Bruce T. Lamb, Ph.D., executive director of the Stark Neurosciences Research Institute.

“Remarkable headway is being made in the field of Alzheimer’s research; however, changes in federal government priorities have hindered opportunities for graduate students and post-doctoral fellows,” said Dan Carmichel, member of Perelman Fellowship organizing committee. “We are thrilled to have the support of generous donors and the Alzheimer’s Association to provide early-career opportunities that will sustain momentum in this new era of Alzheimer’s treatment, brain health, and quality dementia care.”

Bruce T. Lamb, Ph.D., executive director of the Stark Neurosciences Research Institute, added, “Investing in early-career scientists is one of the most effective ways to accelerate discovery. The Perelman Fellowship empowers talented researchers at a critical point in their careers, enabling them to pursue bold, innovative ideas that may ultimately change how we understand and treat Alzheimer’s disease. This partnership reflects our shared commitment to scientific excellence and to building a stronger, more sustainable research pipeline.”

The newly selected Dr. Mel Perelman Fellows include:

Sunwoo Chung, Ph.D.

Dr. Chung is a postdoctoral fellow in medical & molecular genetics at the Indiana University School of Medicine Stark Neurosciences Research Institute. He earned his doctorate from Seoul National University.

In Alzheimer’s disease, problems in the brain’s immune system and the way the brain processes fats (lipids) often go hand in hand. In people with Alzheimer’s, this immune response may be overactive, especially in those with a high-risk gene variant called APOE-e4. Sunwoo Chung, Ph.D., and his team will study how APOE and immune activity affect brain cells in Alzheimer’s using mouse models and lab-grown human brain cells. They will look at how cells with different versions of the APOE gene, especially APOE-e4, handle lipid metabolism and harmful inflammation. This research could help scientists understand why the immune system and fat metabolism both go wrong in Alzheimer’s disease. Future treatments could target these molecular links to reduce brain inflammation and improve how brain cells process fats.

Claudia Mera Reina, M.D., Ph.D.

Dr. Mera Reina is a postdoctoral research fellow in anatomy, cell biology and physiology at the Indiana University School of Medicine Stark Neuroscience Research Institute. She earned her M.D. at the University of Del Rosario in Colombia and her doctorate at the Pontifical Catholic University of Chile.

Recent research suggests that traumatic brain injury (TBI) might increase risk of Alzheimer’s or other dementia and can even accelerate symptoms. The molecular mechanisms behind this connection are unclear.  Mera Reina’s research aims to determine whether increased levels of hexokinase 2 might lead to the brain changes seen in Alzheimer’s and whether this could be reversible.This study will help clarify the role of hexokinase 2 in immune system responses to Alzheimer’s. Results from this study could support additional research into whether hexokinase 2 might represent a new therapeutic target for drugs designed to reduce its levels and prevent Alzheimer’s onset or cognitive symptoms following TBI.

Miguel Moutinho, PharmD, Ph.D

Dr. Moutinho is an assistant professor in the department of medical and molecular genetics at the Indiana University School of Medicine Stark Neurosciences Research Institute. He earned both a PharmD and a Ph.D. in cellular and molecular biology, with a focus on neurobiology, at the Faculty of Pharmacy, University of Lisbon.

In Alzheimer’s disease, the brain’s immune system plays a major role in how damage unfolds. A key part of this system is a protein called TREM2, which is found on microglia, the brain’s immune cells. Dr. Moutinho’s lab will study whether TREM2⁽²¹⁹⁾ helps protect the brain in Alzheimer’s and, if so, how. This project could uncover a new way that the brain tries to protect itself from Alzheimer’s. If proven protective, TREM2⁽²¹⁹⁾ could become a new therapeutic target or biomarker for Alzheimer’s.

Claudia Rangel-Barajas, Ph.D.

Dr. Rangel-Barajas is an assistant research professor of medical and molecular genetics at the Indiana University School of Medicine Stark Neurosciences Research Institute. She currently serves as the Project Manager for the MODELAD consortium, a collaborative effort funded by the National Institute on Aging to standardize and optimize the development of Alzheimer’s disease animal models.

Alzheimer’s disease does not just involve memory loss — it also causes the brain’s immune system to become overactive and inflamed. “Microglia,” the primary immune cells of the brain, play a key role in immune response. A protein known as SHIP1, made by a gene called INPP5D, helps regulate microglia activity. In people with Alzheimer’s, SHIP1 levels are often higher than normal, especially near damaged areas of the brain. Claudia Rangel-Barajas, Ph.D., and her team want to find out if changing the activity of SHIP1 can help or harm the brain in Alzheimer’s disease. This research will clarify whether SHIP1 is a friend or foe in Alzheimer’s. If SHIP1 is found to increase damaging inflammation, then drugs that block it could be a new treatment option. But if blocking SHIP1 makes things worse, researchers will know to avoid that strategy.

[alzindiana]

Looking Back on the Fight to End Alzheimer’s in 2025

As we approach the new year, we are reflecting on some of 2025’s top accomplishments and stories here in Indiana and across the country. Join us in taking a moment to look back at the events, research, advocacy and most of all, the people who made 2025 yet another momentous year in the fight against Alzheimer’s and all other dementia.

January 

Staff and volunteers represented the Greater Indiana Chapter at the 2025 Alzheimer’s Association Community Leaders Summit. During the Summit, the Greater Indiana Chapter was recognized as #4 in the nation for The Longest Day, now Do What You Love to End ALZ, #4 in the nation for the Walk to End Alzheimer’s – Indianapolis. 

Alzheimer’s Association #ENDALZ license plates made their debut at the Indiana Bureau of Motor Vehicles on January 1, 2025. In 2025, nearly 300 Hoosiers have purchased their specialty plate to spread critical awareness and ensure Hoosiers have access to information, resources and support along their journey.

February

Advocates from across Indiana gathered at the Statehouse for the 2025 Alzheimer’s Association State Advocacy Day. Volunteer advocates successfully used their voice, stories and passion to urge their state legislators to make dementia-related legislation a priority.

Volunteers from across the state gathered for the second annual ALZ IN Volunteer Summit. Volunteers learned about the latest developments in research, updates in public policy, and the power of storytelling. Panelists included Dustin Hammers, Ph.D., Kate Foley, Ph.D., Paige Logan, MS, and key volunteer leaders.

March 

With the leadership of Terry and Julie Magid as 2025 co-chairs, we hosted our annual INSPIRE Benefit on Sunday, March 2 raising a record-breaking, more than $850,000 to fund essential caregiver programs and services, education, advocacy and cutting-edge research for Alzheimer’s and all other dementia. In 2025, we saw a 37% growth in fundraising compared to the year prior.

April

Carmel Highschool students Caiden, Wells and Will reinvented their The Longest Day fundraiser to make a splash at the Indiana DECA State and International competitions placing first in Indiana and second internationally for their Alzheimer’s-focused Community Giving Project.

May

On May 16, 2025, the FDA cleared the first blood test to aid in the diagnosis of Alzheimer’s — a major milestone that has the potential to change how the disease is detected and diagnosed. The test, known as the Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, detects amyloid plaques — one of the hallmark features of Alzheimer’s — through a simple blood draw. This marks an important shift toward earlier, less invasive detection.

Mike Hickman of Nobelsville, IN was the May Advocate of the Month. He was recognized for his advocacy efforts and drive to spread awareness about the importance of early detection and treatment access. 

June

More than 1,100 advocates from across the nation, including 14 advocates from Indiana, convened in Washington D.C., for the annual AIM Advocacy Forum. Advocates attended a record 521 scheduled meetings with policymakers to support the Alzheimer’s Association’s 2025 federal legislative priorities.

Greater Indiana Chapter launched “Know Where Alzheimer's Hides,” a public education campaign focusing on the warning signs of Alzheimer's and demonstrating that it can hide in plain sight. The campaign is part of the ALZ Equity for Indiana initiative, a four-year project to connect underserved communities in Indiana to quality dementia care and support.

July

Nearly 19,000 of the brightest minds in dementia science convened in Toronto and online to share the latest research at the Alzheimer’s Association International Conference (AAIC). Two of the 10 awards presented at AAIC to recognize researchers for their innovative contributions to the field were awarded to researchers from Indiana University School of Medicine, Bruce Lamb, PhD and Donna Wilcock, PhD.

The Alzheimer’s Association U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER) — a two-year, multi-site clinical trial testing two different lifestyle interventions in a representative population of older adults at risk for cognitive decline and dementia — found that both interventions improved cognition in older adults at risk of cognitive decline.

August

During our annual Cocktails and Conversations event, the Greater Indiana Chapter Board welcomed four new members, including Terry Magid with Cummins Inc., Kristen Metzger with Elevance Health, Rachel Spehler with CNO Financial Group, and Donna Wilcock, PhD with IU School of Medicine. We look forward to the continued impact these individuals will make as a part of the Alzheimer’s Association Greater Indiana Board in the next year.

The Alzheimer’s Association released the 2025 Health Equity Impact Report: Fostering Collaboration and Understanding highlighting the Association’s efforts and impact in the health equity space for all communities, particularly those who are disproportionately affected and under-resourced.

September

The 2025 Walk to End Alzheimer’s season kicked off in Greater Indiana. In September, Walks were held in Bloomington, East Central Indiana (Richmond), Greater Lafayette, Heartland, Michiana, Porter County and Terre Haute.

The next chapter of The Longest Day arrived! Do What You Love to End ALZ, our signature Do-It-Yourself fundraising event, officially launched in September. Building on the success of The Longest Day,  Do What You Love to End ALZ provides us with the opportunity to grow our impact and engage communities year round.

October

2025 Walk to End Alzheimer’s events came to a close with Columbus, Fort Wayne, Indianapolis, Kokomo, LaPorte, and Lake County taking place the first weekend in October. Greater Indiana rounded out the season with a total of 1,226 teams and 11,132 participants – a 33% growth from 2024. Thanks to sponsors, participants, volunteers and staff, together we raised a record-breaking more than $2.7 million for the first time ever.

November

In honor of National Family Caregivers Month, several caregivers used their voice to showcase the unique challenges caregivers and families affected by Alzheimer's and dementia face each day. Read Kim Raby and Karen Campbell’s stories to learn more.

The Region 9 Alzheimer’s Association staff team, which includes the Illinois, Indiana, and Kentucky chapters, gathered in person in Chicago to collaborate and strategize on effective cross-functional approaches to further the mission of the Alzheimer's Association.

Results from two major new studies testing an oral semaglutide pill for the treatment of early-stage symptomatic Alzheimer’s disease did not demonstrate a statistically significant reduction in Alzheimer’s disease progression. While these results are not what we had hoped for, they build on our understanding of Alzheimer’s. Every clinical trial, regardless of outcome, accelerates what we know about Alzheimer’s and helps inform the next generation of clinical trials.

December

Indiana researchers Sunwoo Chung, Ph.D., Claudia Mera Reina, M.D., Ph.D., Miguel Moutinho, PharmD, Ph.D and Claudia Rangel-Barajas, Ph.D. are the 2025 recipients of the Perelman Fellowship. The Perelman Fellowship supports a wide range of the most promising grant projects, from basic discovery science to studies addressing social and behavioral aspects of Alzheimer’s and related dementias.

Thank you to everyone who helped make this year a success. If you’re interested in getting involved in the fight to end Alzheimer’s in 2026, visit alz.org/Indiana/volunteer and fill out our interest form.

[alzindiana]

Caring from Miles Away - The Hidden Strain of Long-Distance Dementia Care

By Karen Campbell, Board Member, Volunteer, Caregiver

Every morning, I call my mother to make sure she eats breakfast and takes her blood pressure medication. Sometimes she remembers, and sometimes she doesn’t. She’ll ask me the same questions twice in two minutes — “What's today?" or “Where are you living again?" Sometimes she says, “My brain just isn't working today.”

My mother, Virginia, has been living with dementia since 2016. From 600 miles away, I manage her world, scheduling doctors' appointments, paying bills, checking in with her neighbors and coordinating with her weekly caregiver to ensure she is comfortable and cared for. 

As a new mom to a 3-month-old, balancing her needs with my baby’s needs has become more challenging. Yet, becoming a mother while caring for my own has brought everything full circle. As I navigate my own journey of motherhood, I sometimes think about how my mom once did the same for me. Now, as I remind her to eat, to take her medication, and to rest, I realize that the roles have reversed. The cycle of care continues, just in a different direction.

There are moments when I feel pulled in two directions — nurturing new life while tending to the unfair nature of dementia — but I’ve come to see both as expressions of the same love. My mother once gave me her patience and presence, and now I have the privilege to return that to her, even from miles away.

I'm the youngest of four sisters and considered to be the "responsible one." This title comes with heavy responsibilities: Power of Attorney, care coordinator, decision-maker, and often an emotional anchor. Long-distance caregiving can be incredibly stressful and painful. I carry guilt for not being there in person, and fear for what might happen each day from across state lines.

November is National Family Caregivers Month, a time to recognize the more than 12 million Americans who, like me, are providing unpaid care for their loved ones living with Alzheimer's or another form of dementia. 

The Alzheimer's Association recently introduced Transitions in Care, an online program that helps families make informed decisions when a change in care is needed. It walks families through the toughest parts of this journey, like coping with emotions, understanding care options, insurance coverage and more. 

For caregivers who often feel lost, overwhelmed and exhausted, this program can be a lifeline. It certainly has been for me. As I’m now tasked to find the best memory care community for my mom, the Transitions in Care program and other guidance from the Alzheimer’s Association have offered clarity and reassurance that I’m not alone.

This journey has taught me that caregiving, in any form, is an act of love that shapes who we are. I’m learning, from both ends of life, that love is found in showing up, over and over again, even on the hardest days.

So, this National Family Caregivers Month, I'll keep doing what I do each morning. Calling my mom, reminding her to eat breakfast, take her medication, and know she’s loved. And I’ll remind myself that patience and compassion are my greatest tools. I am my mother's caregiver, and that's all that counts. 

[alzindiana]

Greater Indiana Chapter thanks 2025 Walk to End Alzheimer’s participants, sponsors and volunteers

We did it! The 2025 Walk to End Alzheimer’s season has officially come to a close, and what a season it’s been. The Alzheimer’s Association Walk to End Alzheimer’s is the world’s largest event to raise awareness and funds for Alzheimer’s care, support and research. Across the Greater Indiana Chapter, 13 Walks took place this year, joining more than 600 events nationwide.

Walk season wouldn’t be possible without the incredible support of our community — volunteers, team captains, participants and sponsors. Together, you made the 2025 campaign another milestone year in the fight against Alzheimer’s.

This year, more than 1,220 teams and 10,700 participants across Greater Indiana have already raised nearly $2.3 million for Alzheimer’s and dementia research, care and support. Three Walks have surpassed their fundraising goals:

• Terre Haute: 105% to goal

• Greater Lafayette: 102% to goal

• Fort Wayne: 101% to goal

Several Walk to End Alzheimer’s events, including Bloomington, Columbus, Indianapolis, Kokomo and Michiana, are at 75% or more to goal and closing in fast. For the third consecutive year, the Indianapolis Walk also surpassed the $1 million milestone.

On behalf of the Alzheimer’s Association Greater Indiana Chapter and our Board members, thank you for your extraordinary support.

Thank You to Our Sponsors and Volunteers

Our sponsors are vital to this mission — your year-round dedication helps us deepen community connections and reach new audiences. To our Walk committees and volunteers, your energy and commitment make this campaign possible. Thank you for everything you do.

Progress and Hope Ahead

Your commitment is not only building awareness, it’s accelerating science. Not only do we have treatments that can change the course of Alzheimer’s, we now have blood-based biomarkers and guidelines to ensure these new tools can provide earlier, more accurate detection.

We are also at a turning point in what we know about brain health. The results from the Alzheimer’s Association U.S. POINTER — a two-year, randomized controlled clinical trial — provides the rigorous data needed to say with confidence that engaging in a structured lifestyle program targeting multiple risk factors protects brain health across diverse populations at risk for dementia in the U.S.

As a Chapter, in Fiscal Year 2025, we reached 9,900 Hoosiers through our 24/7 helpline, education programs, awareness presentations and support groups, awarded 3 new research grants, and currently have 18 active research grants in Indiana totalling $6.7 million.

Keep the Momentum Going

Although our 2025 Walk events have come to a close, Alzheimer’s isn’t stopping and neither are we. Fundraising continues through Dec. 31, 2025. As we head into the holidays, we encourage you to keep spreading awareness, fundraising or make a self-donation to keep the momentum going in the fight!

Walk participants can also earn prizes through the 2025 Walk incentive program by hitting fundraising goals before your Walk’s deadline. Find deadlines and more information on your Walk website at alz.org/indiana/walk.

We’re so grateful for your passion, generosity and perseverance. With your help, we’re one step closer to our vision of a world without Alzheimer’s and all other dementia.

[alzindiana]

Our FY25 impact across Greater Indiana

As we begin our new fiscal year, we are excited about the opportunities ahead, from groundbreaking research to expanding support and resources for Hoosier families affected by Alzheimer’s and all other dementia. But before we look forward, we want to take a moment to celebrate what we accomplished together in Fiscal Year 2025.

Because of your support, the Alzheimer’s Association Greater Indiana Chapter made a powerful impact across 73 counties in our state. View the full Fiscal Year 2025 Impact Report or find a snapshot below:

9,900 people reached through our 24/7 Helpline, education programs, awareness presentations and support groups

363 education programs and awareness presentations delivered in Indiana communities

3 new research grants awarded in Indiana in FY25 with 18 active research grants in Indiana totaling $6.7 Million

20,000+ social media interactions with an engagement rate above industry benchmark – helping us spread awareness further than ever before

590 volunteer actions to advocate for federal priorities leading to 4 Hoosier members of Congress co-sponsoring Alzheimer’s Association priorities

Collaborated with 21 community organizations to reach underserved Hoosiers and advance health equity

168 Do What You Love to END ALZ (previously known as The Longest Day) fundraising leaders raised a record $471,290 in FY25

45 INSPIRE Benefit Giving Society members contributed to record-breaking fundraising of $861,314 in FY25

8,364 Walk to End Alzheimer’s participants in 13 events raised a record $2,547,256 in 2024

These figures are more than numbers on a page, they represent families finding hope, caregivers receiving guidance, researchers pursuing breakthroughs and communities coming together in the fight to #ENDALZ.

This impact is not possible without you. Thank you for fueling our mission and driving progress in the fight to end Alzheimer’s. We are proud of what we have accomplished together in FY25 and look forward to what we will achieve in FY26.

[alzindiana]

Promising research advancements from AAIC 2025

This week, nearly 19,000 researchers, clinicians, and dementia professionals from around the world came together in Toronto and online for the annual Alzheimer’s Association International Conference (AAIC), the world’s largest international conference dedicated to advancing dementia science and clinical practice.

The research presented at AAIC has the potential to shape the future of Alzheimer’s and other dementia. All week long, the world’s leading researchers presented their latest breakthroughs — discoveries that could lead to improvements in risk reduction, diagnosis, treatment and care.

More than 115 presentations came from dementia researchers across Indiana. Two of the 10 awards presented at AAIC to recognize researchers for their expertise, noteworthy achievements and innovative contributions to the field were awarded to researchers from Indiana University School of Medicine. 

Bruce Lamb, PhD, received the Zaven Khachaturian Award, given to “an individual whose compelling vision, selfless dedication and extraordinary achievement has significantly advanced the field of Alzheimer science.” Donna Wilcock, PhD, received the Bill Thies Award for Distinguished Service to ISTAART (International Society to Advance Alzheimer’s Research and Treatment), the Alzheimer’s Association’s inclusive global network of scientists, clinicians and dementia professionals.

This new era of treatment, research advancements and hope would not be possible without the support and stewardship of Hoosiers like Dr. Lamb and Dr. Wilcock. We are proud of Indiana’s leadership in the fight to end Alzheimer’s and all other dementia.

Highlights from this year’s conference include:

This week marks a turning point in what we know about brain health. Two lifestyle interventions in the U.S. POINTER clinical trial improved cognition in older adults at risk of cognitive decline.

Walking and other lifestyle interventions could benefit people with the strongest known genetic risk for Alzheimer’s disease, the APOE4 gene variant.

The first results from “real world” studies of new amyloid targeting Alzheimer’s drugs confirmed findings from the late-stage clinical trials, and patients expressed satisfaction.

Taking a combination of common drugs to treat blood pressure, cholesterol and diabetes may slow cognitive decline, according to data from five studies.

The Alzheimer’s Association released its first clinical practice guidelines on use of blood biomarker tests by specialists to assist in the diagnosis of Alzheimer’s disease.

Lead in the atmosphere and environment may be linked to memory problems 50 years later, based on a study of more than 600,000 people from a researcher at Purdue University.

Participation in the U.S. Supplemental Nutrition Assistance Program (SNAP) is linked to slower cognitive decline, according to a first-of-its-kind long-term study.

As the leading global convener in the Alzheimer’s and dementia research field, these advancements in research would not be possible without your continued support. Thank you for celebrating the incredible progress we’ve made and for your unwavering commitment to our vision of “a world without Alzheimer’s and all other dementia”.

[alzindiana]

INDIANA UNIVERSITY SCHOOL OF MEDICINE SCIENTIST RECEIVES RESEARCH GRANT FROM THE ALZHEIMER’S ASSOCIATION

The Alzheimer’s Association has awarded more than $159,000 to Claudia Mera Reina MD, M.Sc, PhD, postdoctoral research associate for the Stark Neuroscience Research Institute at Indiana University School of Medicine.

This research aims to better understand the complex relationship between traumatic brain injury (TBI) and Alzheimer’s disease (AD), two severe neurological disorders. TBI can trigger abnormal microglial activity, which may accelerate the development of AD-like pathology. This study focuses on Hexokinase 2 (HK2), a key glycolytic enzyme that drives inflammation in microglia. By investigating the role of HK2 in a mouse model of head injury, this research will help clarify how microglial metabolism contributes to the progression from TBI to AD, potentially uncovering mechanisms that inform future therapeutic approaches.

This grant award comes through the Association’s 2025 International Research Grant Program.

The Alzheimer’s Association funds more Alzheimer’s and dementia research than any other nonprofit globally to accelerate the field towards solutions for the global Alzheimer’s crisis. The Association is currently investing $430 million in more than 1,150 active projects in 57 countries spanning six continents.

“I’m honored to receive this recognition at this point in my career and grateful for the Alzheimer’s Association's support at such a critical moment in research,” said Mera Reina. “My passion lies in translational medicine, the critical link between scientific discovery and clinical application. We are hopeful that this research will contribute to the development of interventions that could benefit individuals at high risk of developing Alzheimer’s disease after brain injury.”

Mera Reina’s passion for research began during her medical studies at Del Rosario University in Colombia. She earned a Ph.D. in molecular and cellular biology at the Pontifical Catholic University of Chile, focusing on cardiovascular disease, and continued with postdoctoral training at the University of Chile. She is now expanding her expertise in the field of neuroscience through postdoctoral research at Indiana University. Her unique combination of clinical training and research experience in two critical areas of human health—cardiovascular and neurological diseases—fuels her commitment to advancing translational medicine.

Mera Reina actively participates in leadership development through various roles at Indiana University. She contributes to the biology efforts around TREM2 at the Target Enablement to Accelerate Therapy Development for Alzheimer's Disease (TREAT-AD) drug discovery center and serves as Mentorship International Chair for the Stark Postdoctoral Association (SPA), where she helps support fellow postdocs. Recent honors include Women in Neuroscience Research and Career Development Award from the Stark Neuroscience Research Institute, participation in the Association Research Fellowship to Promote Diversity Program (AARF-D) and more.

“Indiana has played a key role in many of the advances that are providing life-changing experiences for those living with dementia. We are thrilled to welcome Claudia Mera Reina to our community of researchers and look forward to her discoveries,” said Natalie Sutton, Alzheimer’s Association Greater Indiana Chapter executive. “Her work adds the exciting potential for new therapeutic strategies that could slow the progression of Alzheimer’s, inspiring hope for so many individuals and families who are affected by this terrible disease.”

Alzheimer’s Association funding has led to some of the most important research breakthroughs, including the first Alzheimer’s drug studies and recent treatment discoveries, the ability to visualize Alzheimer’s-related changes in the living brain, and advances toward blood tests. The Association also supports research that improves care for people with dementia and optimizes services for caregivers and families.

Nearly 7 million Americans are living with Alzheimer’s disease and more than 121,000 individuals are living with Alzheimer’s in Indiana alone, according to the Alzheimer’s Disease Facts and Figures, an annual report released by the Alzheimer’s Association. By 2050, the number of people with Alzheimer's is projected to increase to nearly 13 million, barring the development of medical breakthroughs to prevent, slow or stop the disease.

For more information, visit the Alzheimer’s Association at alz.org.

[alzindiana]

Looking Back on the Fight to End Alzheimer’s in 2024

As we approach the new year, we are reflecting on some of 2024’s top accomplishments and stories here in Indiana and across the country. Join us in taking a moment to look back at the events, research, advocacy and most of all, the people who made 2024 yet another momentous year in the fight against Alzheimer’s and all other dementia.

January

Staff and volunteers represented the Greater Indiana Chapter at the 2024 Alzheimer’s Association Community Leaders Summit. During the Summit, the Greater Indiana Chapter was recognized as #5 in the nation for The Longest Day, #5 in the nation for the Walk to End Alzheimer’s – Indianapolis, #5 in the nation for volunteer-led education programs and #4 in the nation for achieving reach goals.

February

During Advocacy Week of Action, the Greater Indiana Chapter advocates pushed for legislation to ensure Hoosiers have access to critical biomarker testing. SB 273 passed the Indiana House of Representatives by a 94-0 vote in February.

Volunteers from across Indiana gathered for the first-ever ALZ IN Volunteer Summit. Volunteers learned about the latest developments in research, the Alzheimer’s Association’s vision for the future, the importance of volunteer engagement and the power of sharing your story.

March

Built on the legacy of Chocolate Sunday, we hosted our inaugural INSPIRE Benefit. The brunch gala in Indianapolis raised more than $620,000 reaching a new record in the 30+ year history of the gala.

State Senator Jean Breaux passed away. Throughout her tenure in the Statehouse, she was a strong supporter of Hoosiers affected by Alzheimer’s and all other dementia. 

April

We teamed up with Gdavis Productions and Films, LLC to bring the incredible play "Unforgettable" to the Circle City. This production raised awareness of the warning signs of dementia, the importance of clinical trials, and the resources available to help those affected by Alzheimer's and other dementias.

The Alzheimer’s Association was again named to The Nonprofit Times Best Nonprofits to Work For list for the 14th year in a row! This year, the Alzheimer’s Association ranked #5 on the list of large nonprofits (more than 250 employees).

Our Hoosier advocates took Capitol Hill by storm during the ALZ Forum, meeting with members of congress and their staff to share their powerful stories.

June

For the third year in a row, we were a proud sponsor of the Indy Pride festival. Staff and volunteers provided attendees with information about the impact of the disease on the LGBTQ+ community and shared resources at MellowChella, a new wind down space for those participating in the festival.

July

FDA granted approval of Kisunla (domanemab) for the treatment of people living with early symptomatic Alzheimer’s disease. We celebrated this approval as more options mean greater opportunity for more time. This marks the third approval of an Alzheimer’s treatment that changes the underlying course of the disease.

More than 12,000 of the brightest minds in dementia science convened in Philadelphia and online to share the latest research at the Alzheimer’s Association International Conference. A large topic of discussion at this year’s conference was the studies to improve both the diagnosis and the treatment of those suffering from Alzheimer’s.

The Centers for Medicare & Medicaid Services (CMS) Innovation Center launched the Guiding an Improved Dementia Experience (GUIDE) Model on July 1, 2024, with 390 participating organizations building Dementia Care Programs (DCPs) that will improve the care and support of people living with dementia and their caregivers with Medicare nationwide.

Greater Indiana Chapter Board welcomed three new members at the start of the Fiscal Year, including Kimberly Grannan with Purdue University Fort Wayne, LaShelle Tipton with IU Health, and Adam Wright with Roche Diagnostics USA. We look forward to the insights and support this dynamic group of individuals will provide to the Alzheimer's Association Greater Indiana Board in years to come.

August

Indiana’s very own, Darlene Bradley, was named the Alzheimer’s Impact Movement August Advocate of the Month and shared her inspiring story to help others living with the disease. Darlene is also a member of the National Early-Stage Advisor Group where she continues to raise awareness around early-stage issues, advocate for change and build momentum toward our vision of a world without Alzheimer's.

Governor Holcomb held a ceremonial signing of SB 273, which ensures access to critical biomarker testing across Indiana. This bill marks a significant step forward in the work we are doing for early diagnosis and detection of Alzheimer’s and other dementias, but our work isn’t done.

September

The 2024 Walk to End Alzheimer’s season kicked off in Greater Indiana and continued through October. Walks were held in Bloomington, Columbus, East Central Indiana (Richmond), Fort Wayne, Greater Lafayette, Heartland (Muncie/Anderson), Indianapolis, Kokomo, Lake County, LaPorte County, Michiana, Porter County and Terre Haute. In all, 1,152 teams and 8,363 participants raised more than $2.5 million for the first time ever.

The Greater Indiana Chapter had the unique opportunity to make a special investment to support the expansion of the LEADS Study. Our investment allowed LEADS research to expand to five international sites, adding to its 18 data collection sites in the U.S..

The Roads and Transportation Committee voted unanimously to approve an Indiana END ALZ specialty license plate. Starting in Jan. 2025, this plate will help raise critical awareness of Alzheimer’s and all other dementia and funds collected through its purchase will ensure Hoosiers have access to the information, resources and support they need to navigate this disease.

October

In early October, we rounded out a successful Greater Indiana 2024 Walk to End Alzheimer’s event season with walks held in Bloomington, Fort Wayne, Kokomo, LaPorte County and Porter County.

The bipartisan NAPA Act and ALZ Investment Act were signed into law. These bills renew our nation's commitment to addressing Alzheimer's by supporting research and improving delivery of clinical care and services.

December

The BOLD Reauthorization Act was signed into law. This means state, local and tribal public health officials will continue having the resources they need to support those impacted by Alzheimer's and all other dementias in their communities.

Thank you to everyone who helped make this year a success. If you’re interested in getting involved in the fight to end Alzheimer’s in 2025, visit alz.org/Indiana/volunteer and fill out our interest form.

[alzindiana]

Show your END ALZ pride on the roads!

The Greater Indiana Chapter has exciting news, Hoosiers! Alzheimer’s Association END ALZ license plates will be available at the Indiana Bureau of Motor Vehicles in 2025. This plate will raise critical awareness of Alzheimer’s and dementia.

When you purchase an END ALZ specialty plate, $25 of your $40 specialty plate fee will serve as a donation to the Alzheimer’s Association and ensure that Hoosiers have access to information, resources and support along their journey.

It's easy - get yours upon normal renewal in 2025, online at IN.gov/BMV or ask for the specialty plate in-person at a BMV license branch at any time starting Jan. 1, 2025.

Each END ALZ specialty plate will begin with alpha indicators "ZA" followed by digits unique to your plate identification.

We hope you’ll consider joining us as we turn Indiana roads purple in the new year!

[alzindiana]

Greater Indiana Chapter thanks 2024 Walk to End Alzheimer’s participants, sponsors and volunteers for a job well done

We did it! The 2024 Walk to End Alzheimer’s event season has come to a close, and what a job well done. The Alzheimer’s Association Walk to End Alzheimer’s is the world’s largest event to raise awareness and funds for Alzheimer’s care, support and research programs. Across the Greater Indiana Chapter, Walk to End Alzheimer’s takes place in 13 communities, with over 600 Walk locations nationwide.

Walk season wouldn't be possible without the support of so many people, including volunteers, team captains, participants, and sponsors. With the community behind us, the 2024 Walk season was yet another momentous campaign in the fight against Alzheimer’s. Take a look at some of the highlights from Greater Indiana’s 2024 Walks.

Across all 13 Walks in Greater Indiana, more than 1,100 teams and 8,200 participants have raised an outstanding $2.23 million for Alzheimer’s and dementia care, support and research. Give yourselves a pat on the back for your tremendous efforts thus far.

At our current fundraising levels, five greater Indiana Walks have surpassed their fundraising goals. Congratulations to the following Walk to End Alzheimer’s communities who have not only met, but exceeded fundraising goals already this season. Your efforts and support for our mission are greatly appreciated.

Michiana - 131% to goal

Kokomo - 123% to goal

LaPorte - 115% to goal

Heartland - 113% to goal

Terre Haute - 100% to goal

Special mention to communities at 80% or more including Bloomington, Columbus, Greater Lafayette, Indianapolis and Lake County. With the support of these communities, we know we can achieve these goals this year. 

For the second consecutive year, the Indianapolis Walk to End Alzheimer’s was also the first Walk in the nation to surpass the $1 million fundraising milestone.

On behalf of the Alzheimer's Association Greater Indiana Chapter and our board of directors, we extend our heartfelt thanks for all of your amazing support of this year's Walk to End Alzheimer's. 

Thank you to our sponsors! You are one of our biggest supporters not only through Walk day activations but your year round dedication to the cause. With your support you’ve allowed us to deepen connection within our local communities and pave a path forward that includes new audiences and opportunities.

To our committee members and volunteers, you are at the core of our mission and Walk to End Alzheimer’s would not be possible without your tireless support, time and energy. Thank you for all that you do to make this campaign a success. 

For the first time, we have treatments that can change the course of Alzheimer’s. While this is a tremendous step forward, our work is far from done. We won’t rest until everyone living with the disease — at any stage — can get the treatment, care and support they need and deserve.

With the support of your participation in Walk, the Alzheimer’s Association is fueling the most promising research in the field, investing in more than 1,100 projects in 56 countries. All of your incredible efforts help fuel groundbreaking treatments like the ones now becoming available — and bring us closer to our vision of a world without Alzheimer’s and all other dementia.

Because of your efforts, in FY24, the Greater Indiana Chapter was able to reach over 10,000 hoosiers through our 24/7 Helpline, numerous education programs, awareness presentations and support groups. Our advocates were able to pass priority bills like Act 273, which requires insurance coverage of biomarker testing in Indiana. And most importantly, your support has allowed us to connect Hoosier to a community that sees them, understands them and is working towards a world without Alzheimer’s and dementia alongside them. 

Although our 2024 Walk events have come to a close, Alzheimer’s isn’t stopping, and neither are we! Fundraising for the 2024 Walk to End Alzheimer’s season continues through Dec. 31, 2024. 

As we head into the holiday season, these are the moments our community needs our support and resources the most. If you feel so inclined, we encourage you to keep fundraising or make a self-donation now through Dec. 31 to show your continued support for our shared mission.

Walk participants also have the opportunity to be rewarded for fundraising efforts through the 2024 Walk to End Alzheimer’s incentive program. Check out the prizes available and aim to hit your goal before Nov. 6, 2024 to earn your rewards.

The Alzheimer’s Association is excited for what the rest of 2024 holds, and we look forward to your continued participation and support through the year and beyond. Thank you to everyone who has helped make this Walk to End Alzheimer’s season a success thus far. 

[alzindiana]

Greater Indiana Chapter thanks Super Early Bird Walk Sponsors, encourages Hoosiers to register for the 2024 Walk

The Alzheimer's Association Walk to End Alzheimer's® is the world's largest event to raise awareness and funds for Alzheimer's care, support and research. That wouldn't be possible without the support of so many people, including volunteers, team captains, participants, and sponsors.

The Alzheimer's Association Greater Indiana Chapter wants to give a special shoutout to the Super Early Bird Sponsors for the 2024 Walk:

Ball State University Encompass Credit Union Friends Fellowship Community Gentry Park Senior Living Hard Rock Casino Northern Indiana IU Health The Law Office of Claire E. Lewis OneAmerica Financial U S #1364 FEDERAL CREDIT UNION ViaQuest Hospice Voelz, Reed, & Mount, LLC

The 2024 Walk begins in Greater Indiana on Sept. 15. Find your local Walk in the schedule below:

Michiana (IN) 09/15/2024 Lake County, IN 09/15/2024 Columbus, IN 09/15/2024 Greater Lafayette, IN 09/21/2024 Terre Haute, IN 09/21/2024 Heartland (IN) 09/28/2024 Indianapolis, IN 09/28/2024 East Central Indiana (Richmond, IN) 09/28/2024 Fort Wayne, IN 10/05/2024 Kokomo, IN 10/05/2024 LaPorte County, IN 10/05/2024 Porter County, IN 10/06/2024 Bloomington, IN 10/06/2024

Be a part of the world's largest event to fight Alzheimer's and all dementia. Register for the Walk at alz.org/indiana/walk.

[alzindiana]

Longest Day Walk of Shelby County gearing up for 4th annual event

Buffy Powers understands the impact of dementia all too well. She has helped care for several family members with the disease, and she works at Infinity Home Care Plus in Shelbyville. All told, she has helped families navigate the disease through case management and care coordination for 35 years.

“It is my passion that everyone should be given ‘victories’ all their lives,” she said. “We should understand the human need to be valued and have opportunities to engage.”

Buffy created one of those opportunities when she began a fundraising event called The Longest Day Walk of Shelby County, which celebrates its 4th year on June 2, 2024. From the beginning, Buffy says service providers throughout the community rallied around the vision for the event.

Now, they fundraise all year long. Events include Paint the Town Purple set for May 15, dine to donate opportunities, raffles and auctions, and an event where people can adopt a butterfly in someone’s honor. In 2023, the event raised more than $5,200.

“At the end of the day, it is about caring for each other, the person with dementia, their families, and their caregivers as we create a community that comes together,” she said.

Her advice to those who are facing the disease is simple: don’t wait – and don’t be afraid to reach out for help.

“Planning and having those hard conversations sooner than later are so important. Being prepared to make an educated decision can help as you ensure your loved one is cared for. Take time to proceed with getting things in order legally with POA (power of attorney), living wills, and other documents as needed. Talk with others, find support and know there are resources that can help support families."

If you need support, help is available around-the-clock – free of charge. Call the Alzheimer’s Association 24/7 Helpline at 800.272.3900.

To get involved with The Longest Day, visit alz.org/tld to register.

[alzindiana]

CarDon & Associates raises funds and awareness through The Longest Day

What do a fish fry, a golf tournament, and a kiss the pig contest have in common? They are all ways that CarDon & Associates Family-first Senior Living Communities raises funds to support the Alzheimer’s Association through The Longest Day.

Inspired by the summer solstice – the day with the most light – The Longest Day encourages people to get involved in the fight to end Alzheimer’s in any way they choose. In keeping with that spirit, each of CarDon’s 19 communities throughout Indiana can decide when and how to raise funds. Events include everything from community bingo games to bake sales and craft fairs.

“The work that the Alzheimer’s Association does is so vital to our communities that offer memory care. So, we really believe in the mission and want to do whatever we can at CarDon to help support that mission.” said Laura​​​​ Bedwell, Regional Director of Cherished Memories.

In the first year, they raised an impressive $5,000. Then, in 2023, CarDon created a specialized web page where teams could register – and see what other communities were doing. “It became competitive,” said Bedwell. “So that was super helpful.”

Thanks to that friendly competition, CarDon raised over $13,000. In 2024, they are hoping to cross the $20,000 mark. “I’m hearing lots of great ideas from the communities of what they have planned, so I’m really hopeful that we will reach that goal.”

In addition to spearheading CarDon’s participation, Bedwell is serving on the 2024 committee for The Longest Day in Indiana. “It has been a great experience to meet other members of the committee and discuss how to reach out and spread the word to get more people involved,” she said.

Bedwell says getting involved has been beneficial for CarDon’s staff, especially those who provide care to those living with the disease.

“It really offers hope,” she said. “I think we can see a lot of pain in the daily care of people with dementia. Getting involved in The Longest Day helps foster hope that there’s research happening, there are good things happening out there, there is support for the families we serve.”

If you are affected by Alzheimer’s or another dementia and need support, call the Alzheimer’s Association free, 24/7 Helpline at 800.272.3900. To get involved with The Longest Day, visit alz.org/tld.